The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(7-Ethoxy-3-methyl-1H-indazole-5-carbonyl)-2'-ethyl-3'-methyl-2'H-spiro[piperidine-4,5'-pyrano[3,2,c]pyrazol]-7'(6'H)-one ID: ALA1958365
PubChem CID: 56949651
Max Phase: Preclinical
Molecular Formula: C24H29N5O4
Molecular Weight: 451.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1cc(C(=O)N2CCC3(CC2)CC(=O)c2nn(CC)c(C)c2O3)cc2c(C)n[nH]c12
Standard InChI: InChI=1S/C24H29N5O4/c1-5-29-15(4)22-21(27-29)18(30)13-24(33-22)7-9-28(10-8-24)23(31)16-11-17-14(3)25-26-20(17)19(12-16)32-6-2/h11-12H,5-10,13H2,1-4H3,(H,25,26)
Standard InChI Key: ONKPFLHZIZWSTR-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
11.7833 -21.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7840 -22.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4949 -22.7805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2096 -22.3697 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2090 -21.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4935 -21.1305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0745 -21.9542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7865 -20.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0745 -20.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3625 -21.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3625 -20.7163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5736 -20.4598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0859 -21.1310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5735 -21.8021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9239 -22.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9234 -23.6076 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6386 -22.3705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3485 -22.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3444 -21.1353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6331 -21.5491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8416 -22.6316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3300 -21.9674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8491 -21.2977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0636 -21.5481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0590 -22.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0765 -19.4792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2609 -21.1310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8484 -20.4165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3185 -22.5867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3419 -20.3103 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0552 -19.8957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0527 -19.0707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0922 -23.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0
15 16 2 0
11 9 1 0
15 17 1 0
10 7 1 0
17 18 2 0
18 25 1 0
7 1 1 0
24 19 1 0
1 8 1 0
19 20 2 0
20 17 1 0
24 25 2 0
8 9 1 0
10 11 1 0
22 23 1 0
2 3 1 0
3 4 1 0
4 5 1 0
21 22 2 0
23 24 1 0
25 21 1 0
5 6 1 0
9 26 2 0
13 27 1 0
11 12 2 0
27 28 1 0
12 13 1 0
14 29 1 0
13 14 1 0
19 30 1 0
14 10 2 0
30 31 1 0
1 2 1 0
31 32 1 0
4 15 1 0
21 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 451.53Molecular Weight (Monoisotopic): 451.2220AlogP: 3.44#Rotatable Bonds: 4Polar Surface Area: 102.34Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.48CX Basic pKa: 2.94CX LogP: 1.37CX LogD: 1.37Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.65Np Likeness Score: -1.28
References 1. Freeman-Cook KD, Amor P, Bader S, Buzon LM, Coffey SB, Corbett JW, Dirico KJ, Doran SD, Elliott RL, Esler W, Guzman-Perez A, Henegar KE, Houser JA, Jones CS, Limberakis C, Loomis K, McPherson K, Murdande S, Nelson KL, Phillion D, Pierce BS, Song W, Sugarman E, Tapley S, Tu M, Zhao Z.. (2012) Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase., 55 (2): [PMID:22148323 ] [10.1021/jm201503u ]